Julian Braun

Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly

CD8 ⁺ T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope

Change in body weight of older adults before and during the COVID-19 pandemic: longitudinal results from the Berlin Aging Study II

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod

Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly

An interdisciplinary approach to characterize peanut‐allergic patients—First data from the FOOD@ consortium

Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial

Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study

Cross-reactive CD4 ⁺ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Cohort profile: follow-up of a Berlin Aging Study II (BASE-II) subsample as part of the GendAge study

Analysis of peripheral inflammatory T cell subsets and their effector function in patients with Birdshot Retinochoroiditis

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19